ZhuZhou QianJin Pharmaceutical Co.,Ltd

Sümbol: 600479.SS

SHH

10.91

CNY

Turuhind täna

17.9517
P/E suhe
0.4616
PEG suhe
4.56B
MRK Cap
0.03%
DIV tootlus

ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 1936.44 M, mis on 0.077 % gowth. Kogu perioodi keskmine brutokasum on 886.049 M, mis on 0.137 %. Keskmine brutokasumi suhtarv on 0.450 %. Ettevõtte eelmise aasta tulemuse puhaskasv on 0.059 %, mis on võrdne 0.123 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes ZhuZhou QianJin Pharmaceutical Co.,Ltd fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.012. Käibevara valdkonnas on 600479.SS aruandlusvaluutas 3514.486. Märkimisväärne osa neist varadest, täpsemalt 1997.9, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.154%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 293.273, kui neid on, aruandlusvaluutas. See näitab erinevust -196.424% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 38.463 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on -0.061%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 2389.672 aruandlusvaluutas. Selle aspekti aastane muutus on 0.078%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 967.023, varude hind on 534.14 ja firmaväärtus 14.07, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 238.27.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
balance-sheet.row.cash-and-short-term-investments	6888.47	1997.9	1731.7	1369.7	1407.6	1378	1100.2	690.3	736.2	544.3	297	205.3	243.2	217.7	334.9	416.9	507.4	527.4	435.8	410.4	383.6	71.3	72.9	93.4
balance-sheet.row.short-term-investments	-97.51	-45.7	491.7	736.8	652.3	-39.6	109.1	182.2	7.8	31.1	69.6	22.1	92.5	98.5	60.3	232	0.2	130	35	6	6.1	0	0	0.2
balance-sheet.row.net-receivables	4356.41	967	983.9	921.6	1164.8	1078.8	972.4	1043	951.2	843.5	876.3	743	610.6	558.1	307.8	260.4	196.8	105.9	113.7	143.4	160.4	113.9	82.8	97.7
balance-sheet.row.inventory	2227.63	534.1	599	547.8	496.8	469.5	440.9	376.3	358.5	272.3	243.2	222.5	195.3	117	126.5	98.8	96.5	82.9	87.3	75.1	84.1	84.9	71	77.5
balance-sheet.row.other-current-assets	281.2	15.4	198.9	78.1	120.2	29	82.9	319.7	87.2	267.7	27	5.6	6.7	-29.7	-12.6	-9.8	-12.1	-4.2	-7.1	-8.7	-13.2	-11.6	-13.5	-19.4
balance-sheet.row.total-current-assets	13753.71	3514.5	3513.5	2917.3	3189.3	2955.3	2596.3	2429.2	2133	1927.8	1443.6	1176.4	1055.8	863.1	756.5	766.3	788.6	711.9	629.7	620.1	614.8	258.5	213.1	249.1
balance-sheet.row.property-plant-equipment-net	2371.59	589.9	622.8	630.2	491	478.7	499.8	529.2	565.4	491.4	415.2	396.8	334.6	309.8	285.4	286.7	193.2	153.4	154.6	160	163	150.2	134.7	77.3
balance-sheet.row.goodwill	56.3	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	14.1	8.7	8.7	8.7	8.7	8.7	8.7	0	0	0	0	0	0
balance-sheet.row.intangible-assets	906.1	238.3	221.8	219.6	216.4	255.2	285.8	241.2	259.8	260.4	247.3	252.8	199.5	45.3	46.5	47.7	47.1	20.2	20.2	4.4	4.6	4.6	4.5	4.6
balance-sheet.row.goodwill-and-intangible-assets	962.39	252.3	235.9	233.7	230.5	269.3	299.9	255.3	273.9	274.5	261.4	266.9	208.2	54	55.2	56.5	55.8	28.9	20.2	4.4	4.6	4.6	4.5	4.6
balance-sheet.row.long-term-investments	965.47	293.3	-304.1	-546.1	-462	103	-63.7	-136.8	37.6	4.3	-33.2	14.2	-57.2	-57	-40.5	-86.9	13.4	54	-16.4	3.9	0.5	0	0	0.4
balance-sheet.row.tax-assets	68.79	22.7	6.6	4.1	4.2	4.2	4.6	6.9	4	3.4	2.5	2.7	1.3	2.1	0.9	0.5	0.5	1.4	0	0	0	0	0	1.3
balance-sheet.row.other-non-current-assets	141.8	4.2	547.3	821	775.7	1.7	135.7	203	18.2	41.9	139.5	31.2	102.4	109.7	71	242.8	7.9	135.6	40.7	9.8	9.7	7.9	7.6	0
balance-sheet.row.total-non-current-assets	4510.04	1162.4	1108.5	1143	1039.4	856.9	876.2	857.6	899.1	815.4	785.4	711.9	589.4	418.6	371.9	499.5	270.8	373.3	199	178.1	177.7	162.8	146.8	83.6
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	18263.75	4676.9	4622	4060.2	4228.7	3812.2	3472.5	3286.9	3032.1	2743.2	2228.9	1888.3	1645.2	1281.7	1128.5	1265.8	1059.4	1085.3	828.7	798.2	792.5	421.3	359.9	332.8
balance-sheet.row.account-payables	2617.36	647.5	780.9	511.7	623	529.1	485.8	469.5	446	317	369.4	168.9	86.1	80.2	80.7	109	91.7	82	81	56.1	69.5	74.6	49.1	77.3
balance-sheet.row.short-term-debt	279.3	78.2	79.5	88.6	135.9	1.9	1	1	0.5	3.1	61	87	115.9	0	0	131	0	0	0	0	12	33.1	32.8	1.5
balance-sheet.row.tax-payables	218.03	70.6	72.5	35.6	45.2	41	61.3	67.5	32.9	23.1	41.6	28.4	28.4	34.3	10	15.2	26.6	23.7	23.2	11.3	11.6	18.9	17.1	12.9
balance-sheet.row.long-term-debt-total	144.84	38.5	44.8	60.3	19.5	20.5	26.7	37.3	47.3	54	32	5.2	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	8.7
Deferred Revenue Non Current	155.79	38	44.4	51.3	51.8	42.8	44.4	51.5	50.2	52.9	41.6	44.5	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	78.35	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	280.05	69.1	705.6	75.5	84.9	192.3	407.8	130.1	165.4	149.6	125	97.9	76.8	181.3	81.5	19.5	89.4	83.6	85.5	144.7	1.9	5.5	1.6	0.7
balance-sheet.row.total-non-current-liabilities	407.36	108.3	108.5	131.9	89	81.5	86.6	111.3	111.2	117.6	84.3	55.3	30	26.6	26.5	2.6	2.6	23.7	2.6	2.6	3	3.4	3.4	11.5
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	110.84	31.5	32.8	44.8	42.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	6493.32	1650.1	1805.7	1360.3	1466.7	1182.6	1042.5	1045.7	948.2	779.2	843.2	683.9	581.2	288.1	188.6	314.5	183.7	189.3	169.1	203.4	148.4	188.2	174.3	182.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1716.69	428.9	429.8	418.5	418.5	418.5	418.5	348.8	348.8	348.8	304.8	304.8	304.8	304.8	304.8	217.7	181.4	151.2	126	84	56	38	38	38
balance-sheet.row.retained-earnings	4286.33	1142.5	970.8	930.7	1047.2	959.4	826.1	694.2	568.4	481.4	456.1	414.1	377.7	328.3	328.2	356.9	295.8	260.5	115.5	60.7	122.1	114.1	71.9	57.3
balance-sheet.row.accumulated-other-comprehensive-income-loss	2362.59	280.8	275.3	298.1	298.1	297.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	933.42	537.5	540.3	503	503	503	784.2	834.4	828.5	816.7	360.6	289.3	283.5	275.2	268.6	349.4	374.2	463	399	433.8	452.5	64.8	56	40.1
balance-sheet.row.total-stockholders-equity	9299.03	2389.7	2216.2	2150.4	2266.8	2178.1	2028.8	1877.4	1745.7	1646.8	1121.5	1008.2	966	908.3	901.6	924	851.4	874.6	640.6	578.5	630.6	216.9	165.8	135.4
balance-sheet.row.total-liabilities-and-stockholders-equity	18263.75	4676.9	4622	4060.2	4228.7	3812.2	3472.5	3286.9	3032.1	2743.2	2228.9	1888.3	1645.2	1281.7	1128.5	1265.8	1059.4	1085.3	828.7	798.2	792.5	421.3	359.9	332.8
balance-sheet.row.minority-interest	2471.4	637.1	600.1	549.5	495.2	451.5	401.1	363.8	338.2	317.2	264.3	196.2	98	85.3	38.2	27.3	24.3	21.3	19	16.4	13.5	16.1	19.7	14.5
balance-sheet.row.total-equity	11770.43	3026.8	2816.3	2699.9	2762	2629.6	2430	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	18263.75	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	867.96	247.6	187.6	190.8	190.3	63.4	45.3	45.3	45.3	35.3	36.3	36.3	35.3	41.6	19.8	145.1	13.6	184	18.6	10	6.5	6.5	5.5	0.5
balance-sheet.row.total-debt	424.14	116.7	124.2	148.9	155.4	22.4	27.7	38.3	47.8	57.1	93	87	115.9	0.7	0.7	131	0.7	0.7	0.7	0.7	12	33.1	32.8	1.5
balance-sheet.row.net-debt	-6414.01	-1881.2	-1115.7	-484	-600	-1355.5	-963.4	-469.8	-680.6	-456.1	-134.4	-96.2	-34.8	-118.5	-274	-53.9	-506.6	-396.7	-400.1	-403.7	-365.5	-38.2	-40.1	-91.7

Rahavoogude aruanne

ZhuZhou QianJin Pharmaceutical Co.,Ltd finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab -0.429 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab -0.207 erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli 585285163.000. See on 3.792 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 103.65, 0.06, -50.72, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -147.89 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -13.06, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
cash-flows.row.net-income	278.61	395	388.3	374.7	360.2	352.1	302.6	246.7	173.4	88.3	117.7	128.8	130.9	94.8	97.6	136.9	134.5	176.6	75	61.7	46.6	48.4	38.9
cash-flows.row.depreciation-and-amortization	14.07	103.7	95.6	85.9	60.9	61.1	61.8	62.7	50.2	50.4	48.5	48.3	40	38.3	36	25.2	21.8	20.9	24.3	23.3	22	18.3	13.1
cash-flows.row.deferred-income-tax	-73.79	-2.8	-3.6	2.7	1.4	-0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	18.19	2.8	3.6	-2.7	-1.4	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	53.6	-81.7	246.9	65.8	129.5	-233	29.3	-11.8	-81.8	-73.8	15.1	-49.5	40.4	-122.7	-81.4	-68.9	-88.6	2.4	47.2	-1.1	-46.4	-19.4	-45.6
cash-flows.row.account-receivables	-8.69	-8.7	-163.7	275.9	27.2	-362.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	62.29	62.3	-51.2	-52.4	-27.3	-29.1	-64.7	-17.9	-85.5	-29.9	-22.4	-19.8	-78.4	9.6	-27.7	-2	-13.2	3.7	1.7	8.3	1	-13.8	3.1
cash-flows.row.account-payables	0	-132.5	465.4	-160.4	128.2	159.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-2.8	-3.6	2.7	1.4	-0.9	94	6.1	3.8	-44	37.4	-29.6	118.8	-132.3	-53.7	-66.8	-75.4	-1.3	45.5	-9.4	-47.4	-5.6	-48.7
cash-flows.row.other-non-cash-items	191.12	26.1	2.7	-40.9	-8.2	-24.7	-10.2	-14.1	-0.9	2.6	2.1	10.1	-13.6	12.2	-13	-19.7	-30.4	-120.6	-26.3	-7.5	-3.8	3.6	-0.3
cash-flows.row.net-cash-provided-by-operating-activities	474.21	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-36.4	-44	-34.4	-71.9	-97.2	-40.6	-46.4	-57.3	-81.5	-84.5	-66	-84.3	-256.3	-63.9	-58.4	-123.3	-95.3	-22.5	-21.4	-16.7	-56.5	-34	-59.2
cash-flows.row.acquisitions-net	0.06	0	0.2	30.8	103.6	73	0	13	0.7	85	1.2	-21.4	0.6	1.3	5.8	0.8	0.3	0.8	2.1	0.6	1	0.1	0.2
cash-flows.row.purchases-of-investments	-100.06	-402	-2102	-1570	-2641	-285	-904	-1403.9	-1001.7	-769.6	-405	-135.1	-235.4	-891.1	-565.5	-1545.8	-1482	-576.3	-855.2	-1103.4	-225.3	-1	-5
cash-flows.row.sales-maturities-of-investments	357.66	1031.2	2258.4	1567.7	1770.3	469.5	1222.9	1006.1	1197.1	605.1	357.6	207.4	266.3	820.6	889.9	1194	1728.4	549.6	845.8	1107.5	219.4	0.5	0.3
cash-flows.row.other-investing-activites	75.41	0.1	0	0	-97.2	-40.6	2.5	24.3	5.9	-84.5	0.4	0.1	0	-3.9	1.6	2.8	2.8	3.1	2.4	1.8	3.7	2	1.6
cash-flows.row.net-cash-used-for-investing-activites	221.32	585.3	122.1	-43.3	-961.5	176.3	275	-417.8	120.6	-248.5	-111.8	-33.3	-224.7	-137	273.3	-471.5	154.1	-45.3	-26.3	-10.3	-57.8	-32.5	-62.2
cash-flows.row.debt-repayment	-50.72	-50.7	-15	-127.6	-19.1	-6.2	-10.6	-9.5	-9.3	-105	-147	-180.9	-7.5	-20	-605	-4937	0	-550	-700	-12	-333.7	-39.7	-15.3
cash-flows.row.common-stock-issued	1.41	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-3.38	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-165.13	-147.9	-248.6	-429.5	-209.3	-167.1	-105	-71.4	-54.4	-66.7	-60.7	-79.9	-61.3	-76.2	-108.9	-59.5	-79.6	-36.4	-96	-28.2	-32.1	-22	-7.7
cash-flows.row.other-financing-activites	-17.62	-13.1	-0.5	36.5	124.2	-7.4	-9.1	-12.7	-1.2	620	154.9	180.8	125	55.2	497.8	5065.6	-1.9	548.9	698.6	0.9	711.3	41.7	58.8
cash-flows.row.net-cash-used-provided-by-financing-activities	-219.51	-202	-264.2	-520.6	-104.2	-180.7	-124.7	-93.6	-65	448.4	-52.8	-80	56.2	-41.1	-216.1	69.1	-81.5	-37.4	-97.3	-39.3	345.5	-20	35.8
cash-flows.row.effect-of-forex-changes-on-cash	-8.88	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	467.14	826.4	591.4	-78.3	-523.4	151.1	533.7	-227.9	196.4	267.4	18.8	24.3	29.3	-155.4	96.3	-328.9	109.9	-3.4	-3.6	26.9	306.2	-1.5	-20.3
cash-flows.row.cash-at-end-of-period	6497.52	1928.3	1101.9	510.5	588.8	1112.3	961.2	427.4	655.4	458.9	191.5	172.8	148.5	119.2	274.6	178.4	507.2	397.4	400.8	404.3	377.5	71.3	72.9
cash-flows.row.cash-at-beginning-of-period	6030.38	1101.9	510.5	588.8	1112.3	961.2	427.4	655.4	458.9	191.5	172.8	148.5	119.2	274.6	178.4	507.2	397.4	400.8	404.3	377.5	71.3	72.9	93.2
cash-flows.row.operating-cash-flow	474.21	443.1	733.5	485.6	542.4	155.5	383.5	283.5	140.9	67.5	183.3	137.6	197.8	22.6	39.1	73.5	37.2	79.3	120.1	76.5	18.5	51	6.1
cash-flows.row.capital-expenditure	-36.4	-44	-34.4	-71.9	-97.2	-40.6	-46.4	-57.3	-81.5	-84.5	-66	-84.3	-256.3	-63.9	-58.4	-123.3	-95.3	-22.5	-21.4	-16.7	-56.5	-34	-59.2
cash-flows.row.free-cash-flow	437.81	399.1	699	413.7	445.1	114.9	337.1	226.2	59.4	-17	117.4	53.4	-58.4	-41.3	-19.3	-49.8	-58.1	56.7	98.7	59.8	-38	16.9	-53.2

Kasumiaruande rida

ZhuZhou QianJin Pharmaceutical Co.,Ltd tulud muutusid võrreldes eelmise perioodiga -0.057%. 600479.SS brutokasum on teatatud 1751.76. Ettevõtte tegevuskulud on 3337.92, mille muutus võrreldes eelmise aastaga on 154.481%. Kulud amortisatsioonikulud on 103.65, mis on -0.005% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 3337.92, mis näitab 154.481% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab 0.037% kasvu võrreldes eelmise aastaga. Tegevustulu on 460.57, mis näitab 0.037% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on 0.059%. Eelmise aasta puhaskasum oli 320.41.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002
income-statement-row.row.total-revenue	3839.03	3798.5	4026.3	3663.8	3627	3525.2	3328.6	3182.7	2864.9	2446.7	2194.2	1972.9	1583.4	1256.5	979.4	904.3	801.4	679.8	602.7	665.8	604.9	686.8	582	560.2
income-statement-row.row.cost-of-revenue	2054.9	2046.7	2289.9	2032.2	2030.8	1918.7	1776.3	1743.2	1573.3	1311.5	1141.1	1006.8	786.3	603.5	427.9	360.8	345.8	322.3	309.4	423.8	409.4	476.1	405.9	417.3
income-statement-row.row.gross-profit	1784.14	1751.8	1736.4	1631.6	1596.2	1606.5	1552.3	1439.5	1291.6	1135.2	1053.1	966	797.1	653	551.6	543.4	455.6	357.5	293.3	242	195.5	210.7	176.1	142.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	185.64	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	68.58	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	884.41	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-840.99	-3337.9	218.6	189.1	156.1	147.8	14.9	-9.7	13.6	15	10.5	3.7	0.7	1.6	8.1	1.7	-1.1	0.1	1.2	1.3	1.8	-0.8	-0.9	-2
income-statement-row.row.operating-expenses	1892.94	3337.9	1311.7	1261.1	1224.8	1247.8	1249.1	1170.9	1111.7	1042.9	924.3	810.4	663.7	536.5	474	404.5	345.3	282.9	237.7	178	146.3	142.3	118.1	92.9
income-statement-row.row.cost-and-expenses	3399.17	3337.9	3601.5	3293.4	3255.6	3166.5	3025.4	2914.1	2685	2354.4	2065.4	1817.2	1450	1140.1	901.8	765.3	691	605.2	547.1	601.8	555.7	618.4	524	510.1
income-statement-row.row.interest-income	48.46	51.4	9.8	11.9	30.4	38.6	20.9	11.7	10.9	4.6	1.2	0.2	1.7	4.1	1.6	0	0	0	2.4	1.8	3.7	1.9	1.6	1.7
income-statement-row.row.interest-expense	1.26	1.7	2.2	2.1	2.2	0.4	0.7	2.6	2.8	6.5	6.1	4.1	2.1	0.2	0.1	-1	-1.9	0.7	1.1	0.1	1.2	2.3	1.1	0.3
income-statement-row.row.selling-and-marketing-expenses	884.41	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-1.23	-1.5	1.6	-2.8	0.4	-1.1	49.1	18	26.5	17.3	11.6	-2.8	17.9	-6.8	31.9	17.1	31.4	123.3	27.9	9.1	6.5	1.2	1.3	-0.5
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-840.99	-3337.9	218.6	189.1	156.1	147.8	14.9	-9.7	13.6	15	10.5	3.7	0.7	1.6	8.1	1.7	-1.1	0.1	1.2	1.3	1.8	-0.8	-0.9	-2
income-statement-row.row.total-operating-expenses	-1.23	-1.5	1.6	-2.8	0.4	-1.1	49.1	18	26.5	17.3	11.6	-2.8	17.9	-6.8	31.9	17.1	31.4	123.3	27.9	9.1	6.5	1.2	1.3	-0.5
income-statement-row.row.interest-expense	1.26	1.7	2.2	2.1	2.2	0.4	0.7	2.6	2.8	6.5	6.1	4.1	2.1	0.2	0.1	-1	-1.9	0.7	1.1	0.1	1.2	2.3	1.1	0.3
income-statement-row.row.depreciation-and-amortization	-79.84	103.7	104.2	47.3	60.3	40.8	61.8	62.7	50.2	50.4	48.5	48.3	40	38.3	36	25.2	21.8	20.9	24.3	23.3	22	18.3	13.1	-1.9
income-statement-row.row.ebitda-caps	486.32	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	465.79	460.6	444.2	436.2	424.2	430.8	337.4	296.3	194	94.8	130.4	150	150.9	108.1	101.5	155.2	143.1	198.9	83.9	74.3	55.3	71.5	60.2	51.9
income-statement-row.row.income-before-tax	464.56	459.1	445.8	433.4	424.6	429.7	352.3	286.6	206.4	109.6	140.4	152.8	151.3	109.7	109.5	156.1	141.8	197.9	84.3	74.3	56.4	70.1	59.3	49.7
income-statement-row.row.income-tax-expense	66.62	65.4	57.6	58.7	64.4	77.6	49.7	40	33	21.3	22.7	24.1	20.4	14.9	12	19.1	7.3	21.3	9.4	12.6	9.8	21.7	20.3	14.4
income-statement-row.row.net-income	278.61	320.4	302.5	302.1	297.1	294.3	255.4	207.8	149.4	93	105.1	123.8	120.2	82.8	86.4	130.9	129.9	173.6	71.8	59.9	45.4	50.1	39.8	34.5